- Home
- NMRA vs JMSB Comparison
NMRA vs JMSB Comparison
Compare NMRA & JMSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- JMSB
- Stock Information
- Founded
- NMRA 2019
- JMSB 2005
- Country
- NMRA United States
- JMSB United States
- Employees
- NMRA N/A
- JMSB N/A
- Industry
- NMRA
- JMSB Major Banks
- Sector
- NMRA
- JMSB Finance
- Exchange
- NMRA Nasdaq
- JMSB Nasdaq
- Market Cap
- NMRA 121.0M
- JMSB 246.7M
- IPO Year
- NMRA 2023
- JMSB N/A
- Fundamental
- Price
- NMRA $0.78
- JMSB $19.15
- Analyst Decision
- NMRA Buy
- JMSB
- Analyst Count
- NMRA 8
- JMSB 0
- Target Price
- NMRA $9.29
- JMSB N/A
- AVG Volume (30 Days)
- NMRA 1.4M
- JMSB 18.7K
- Earning Date
- NMRA 08-05-2025
- JMSB 07-23-2025
- Dividend Yield
- NMRA N/A
- JMSB 1.55%
- EPS Growth
- NMRA N/A
- JMSB 475.76
- EPS
- NMRA N/A
- JMSB 1.24
- Revenue
- NMRA N/A
- JMSB $54,782,000.00
- Revenue This Year
- NMRA N/A
- JMSB N/A
- Revenue Next Year
- NMRA N/A
- JMSB N/A
- P/E Ratio
- NMRA N/A
- JMSB $15.40
- Revenue Growth
- NMRA N/A
- JMSB 50.81
- 52 Week Low
- NMRA $0.61
- JMSB $13.81
- 52 Week High
- NMRA $17.19
- JMSB $26.52
- Technical
- Relative Strength Index (RSI)
- NMRA 48.23
- JMSB 68.33
- Support Level
- NMRA $0.72
- JMSB $18.48
- Resistance Level
- NMRA $0.85
- JMSB $18.99
- Average True Range (ATR)
- NMRA 0.07
- JMSB 0.44
- MACD
- NMRA -0.01
- JMSB 0.11
- Stochastic Oscillator
- NMRA 23.99
- JMSB 92.90
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.